
Metformin (500mg) + Sitagliptin (100mg)
Active composition
+1 more active ingredient
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
Sitagliptin inhibits DPP-4, increasing incretin levels, which stimulate insulin release and reduce glucagon secretion.
Medical applications
Emsita M 100mg/500mg Tablet SR is a combination medication containing Sitagliptin and Metformin used to help manage blood glucose levels in individuals with diabetes. Sitagliptin works by increasing the activity of incretin hormones that regulate insulin release and reduce glucose production after meals. Metformin helps decrease glucose production in the liver and improves the body’s response to insulin. Together these medicines help maintain stable blood sugar levels and support better glycemic control. The sustained release formulation allows the medication to release gradually, providing longer lasting action throughout the day. Proper blood glucose control is important for preventing complications related to diabetes and supporting overall metabolic health. The medicine is usually taken according to the dosage recommended by a healthcare professional. When used as directed, Emsita M 100mg/500mg Tablet SR helps support effective diabetes management and improved metabolic balance.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Information regarding the use of Emsita M 100mg/500mg Tablet SR during pregnancy is not available. Please consult your doctor.
High Risk
Emsita M 100mg/500mg Tablet SR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Medical Advice
Emsita M 100mg/500mg Tablet SR should be used with caution in patients with kidney disease. Dose adjustment of Emsita M 100mg/500mg Tablet SR may be needed. Please consult your doctor. Use of Emsita M 100mg/500mg Tablet SR is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.
Exercise Caution
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Consult Doctor
Emsita M 100mg/500mg Tablet SR is probably unsafe to use in patients with liver disease and should be avoided. Please consult your doctor.
Regular Checkup
0 reviews for Emsita M 100mg/500mg Tablet SR

Sitagliptin (100mg) + Metformin (500mg)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
+1 more active ingredient
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
Sitagliptin inhibits DPP-4, increasing incretin levels, which stimulate insulin release and reduce glucagon secretion.
Medical applications
Emsita M 100mg/500mg Tablet SR is a combination medication containing Sitagliptin and Metformin used to help manage blood glucose levels in individuals with diabetes. Sitagliptin works by increasing the activity of incretin hormones that regulate insulin release and reduce glucose production after meals. Metformin helps decrease glucose production in the liver and improves the body’s response to insulin. Together these medicines help maintain stable blood sugar levels and support better glycemic control. The sustained release formulation allows the medication to release gradually, providing longer lasting action throughout the day. Proper blood glucose control is important for preventing complications related to diabetes and supporting overall metabolic health. The medicine is usually taken according to the dosage recommended by a healthcare professional. When used as directed, Emsita M 100mg/500mg Tablet SR helps support effective diabetes management and improved metabolic balance.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Information regarding the use of Emsita M 100mg/500mg Tablet SR during pregnancy is not available. Please consult your doctor.
High Risk
Emsita M 100mg/500mg Tablet SR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Medical Advice
Emsita M 100mg/500mg Tablet SR should be used with caution in patients with kidney disease. Dose adjustment of Emsita M 100mg/500mg Tablet SR may be needed. Please consult your doctor. Use of Emsita M 100mg/500mg Tablet SR is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.
Exercise Caution
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Consult Doctor
Emsita M 100mg/500mg Tablet SR is probably unsafe to use in patients with liver disease and should be avoided. Please consult your doctor.
Regular Checkup
0 reviews for Emsita M 100mg/500mg Tablet SR













